(0.02%) 5 470.65 points
(0.15%) 39 172 points
(0.28%) 17 767 points
(0.09%) $80.90
(-5.04%) $2.62
(-0.82%) $2 311.60
(-0.17%) $28.82
(3.22%) $1 018.20
(0.34%) $0.936
(0.75%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
0.00% $ 29.06
Live Chart Being Loaded With Signals
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases...
Stats | |
---|---|
Volumen de hoy | 0 |
Volumen promedio | 625 748 |
Capitalización de mercado | 1.27B |
EPS | $-0.480 ( Q3 | 2022-11-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-14.46 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.860 (2.96%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-02-24 | 5am Partners Vi, Llc | Sell | 496 323 | Common Stock |
2023-02-24 | Healy James | Sell | 9 803 | Common Stock |
2022-11-28 | Healy James | Sell | 6 000 | Common Stock |
2023-02-24 | Healy James | Sell | 19 608 | Common Stock |
2023-02-24 | Healy James | Sell | 6 073 949 | Common Stock |
INSIDER POWER |
---|
-75.98 |
Last 98 transactions |
Buy: 39 839 974 | Sell: 98 795 779 |
Volumen Correlación
CinCor Pharma, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CinCor Pharma, Inc. Correlación - Moneda/Commodity
CinCor Pharma, Inc. Finanzas
Annual | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1 422.09 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1 422.09 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.950 |
FY | 2019 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.214 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
CinCor Pharma, Inc.
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico